RT Journal Article
SR Electronic
A1 Gordon, Debra
T1 Noninsulin Antidiabetic Agents: Typical and Atypical Effects
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 9
SP 34
OP 35
DO 10.1177/155989771009016
UL http://mdc.sagepub.com/content/10/9/34.abstract
AB The incretin mimemics—dipeptidyl peptidase-4 (DPP-4) inhibitors and the glucagon-like peptide-1 (GLP-1) receptor agonists—stimulate insulin secretion and inhibit glucagon secretion to stabilize serum glucose levels. They provide blood glucose reductions that are similar to other antidiabetic drugs, with no associated weight gain and, in the case of the GLP-1 agonists, some weight loss [Drucker DJ, Nauck MA. Lancet 2006; Russell-Jones D. Int J Clin Pract 2010].